Medical Device and Diagnostic Industry (MD+DI)

Senseonics' CEO Talks Plan to Out-Innovate Dexcom, Abbott, and More

Senseonics CEO Tim Goodnow discusses 103% patient growth, year-long Eversense CGM, AI integration, and how implantable tech ...
The Motley Fool

If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today

DexCom's returns over the past decade have been solid, but not quite on par with the market's. The company has encountered some headwinds in recent years that have sunk its stock price. Despite the ...
Hosted on MSN

Why DexCom Stock Is Crashing Today

DexCom beat expectations in the third quarter, and it raised its revenue guidance for the full year. Manufacturing issues are putting pressure on margins. For 2026, the company sees growth missing ...
The Motley Fool

DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price?

Why have investors been so bearish on DexCom? DexCom makes continuous glucose monitoring (CGM) devices, which are crucial for people with diabetes who have high glucose levels. There are also CGMs now ...